{"schema_version":"secwatch.filing_event.v1","accession":"0001609550-24-000042","form_type":"8-K","ticker":"INSP","cik":"0001609550","company_name":"Inspire Medical Systems, Inc.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.762144+00:00","generated_at":"2026-05-31T12:17:22.100237+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Inspire Q2 revenue $195.9M (+30% YoY), EPS $0.32; raises FY guide, authorizes $150M buyback","bullets":["Q2 revenue $195.9M (30% YoY), net income $9.8M vs loss $12.0M; diluted EPS $0.32 vs ($0.41).","FY 2024 revenue guidance raised to $788-798M (26-28% growth); EPS guidance raised to $0.60-0.80 from $0.10-0.20.","Board authorized $150M share repurchase program, first in company history, expiring August 5, 2026.","Received FDA approval for Inspire V neurostimulation system and EU MDR CE Mark for full-body MRI compatibility.","Activated 81 new U.S. centers in Q2 (total 1,316) and added 12 sales territories (total 310)."],"urls":{"canonical":"https://secwatch.observer/filing/0001609550-24-000042","json":"https://secwatch.observer/filing/0001609550-24-000042.json","markdown":"https://secwatch.observer/filing/0001609550-24-000042.md","text":"https://secwatch.observer/filing/0001609550-24-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1609550/000160955024000042/0001609550-24-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1609550/000160955024000042/insp-20240806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:17:22.100237+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}